Dr. Reddy's To Launch Generic Vascepa In US | AMRN Message Board Posts


Amarin Corporation plc

  AMRN website

AMRN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  8567 of 8608  at  6/22/2021 11:56:16 AM  by

ex_hacker202


Dr. Reddy's To Launch Generic Vascepa In US

 Doubt this impacts DRL's Sherman Act lawsuit against AMRN because they're claiming AMRN hogging API supply resulted in DRL not being able to launch GV in a timely fashion, not that it was completely blocked from launching at all.
 

Dr. Reddy's Laboratories Limited (NYSE:RDY) announced the launch of generic version of Amarin Corporation plc's (NASDAQ:AMRN) icosapent ethyl capsules, 1 gram, approved by the FDA. The capsules have been approved as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.

 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0  
   Views: 0 [4]
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...